4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Rani Therapeutics Holdings, Inc. (RANI) operates in the Biotechnology industry and is headquartered in San Jose, United States with about 69 employees. Its market capitalization is roughly $96 million. In the fiscal year ended 2025-12-31, RANI reported $2M in revenue and ($30M) in net income.
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States.
Interactive charts & full statements → Open the RANI valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $2M | $1M | $0M | $0M | — |
| Operating Income (EBIT) | ($38M) | ($50M) | ($66M) | ($64M) | — |
| Net Income | ($30M) | ($30M) | ($34M) | ($31M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $2M | $2M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($8M) | ($8M) | ($7M) | ($10M) | ($12M) |
| Net Income | ($7M) | ($10M) | ($5M) | ($7M) | ($7M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $59M | $37M | $58M | $108M | — |
| Total Liabilities | $17M | $33M | $32M | $34M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive RANI viewer.
About TickerBase · Data methodology & sources